Asian Society of Gynecologic Oncology International Workshop 2018. J Gynecol Oncol. 2019 Mar;30(2):e39.

Perioperative outcomes of extensive bowel resection during cytoreductive surgery in patients with advanced ovarian cancer. J Surg Oncol. 2019 Feb 8.

Revised FIGO staging for carcinoma of the cervix uteri. Int J Gynaecol Obstet. 2019 Apr;145(1):129-135

Risk factors for septic adverse events and their impact on survival in advanced ovarian cancer patients treated with neoadjuvant chemotherapy and interval debulking surgery. Gynecol Oncol. 2018 Oct;151(1):32-38.

Efficacy, Immunogenicity, and Safety of a 9-Valent Human Papillomavirus Vaccine: Subgroup Analysis of Participants From Asian Countries. J Infect Dis. 2018 Jun 5;218(1):95-108

A study of clinicopathologic factors as indicators for early prediction of suboptimal debulking surgery after neoadjuvant chemotherapy in advanced ovarian cancer. J Obstet Gynaecol Res. 2018 Jul;44(7):1294-1301

An Open-Label, Randomized, Parallel, Phase II Trial to Evaluate the Efficacy and Safety of a Cremophor-Free Polymeric Micelle Formulation of Paclitaxel as First-Line Treatment for Ovarian Cancer: A Korean Gynecologic Oncology Group Study (KGOG-3021). Cancer Res Treat. 2018 Jan;50(1):195-203

Porta hepatis debulking procedures as part of primary cytoreductive surgery for advanced ovarian cancer. Gynecol Oncol. 2017 Sep;146(3):672-673.

Long-term results of early adjuvant concurrent chemoradiotherapy for high-risk, early stage uterine cervical cancer patients after radical hysterectomy. BMC Cancer. 2017 Apr 28;17(1):297

Predicting Model of Lymph Node Metastasis Using Preoperative Tumor Grade, Transvaginal Ultrasound, and Serum CA-125 Level in Patients With Endometrial Cancer. Int J Gynecol Cancer. 2016 Nov;26(9):1630-1635.

Lymphatic Leak Occurring After Surgical Lymph Node Dissection: A Preliminary Study Assessing the Feasibility and Outcome of Lymphatic Embolization. Cardiovasc Intervent Radiol. 2016 Dec;39(12):1728-1735

Treatment outcomes in patients with FIGO stage IB-IIA cervical cancer and a focally disrupted cervical stromal ring on magnetic resonance imaging: A propensity score matching study. Gynecol Oncol. 2016 Oct;143(1):77-82.

Survival impact based on the thoroughness of pelvic lymphadenectomy in intermediate- or high-risk groups of endometrioid-type endometrial cancer: A multi-center retrospective cohort analysis. Gynecol Oncol. 2016 Jun;141(3):440-446

Pretreatment serum CYFRA 21-1 level correlates significantly with survival of cervical cancer patients: a multivariate analysis of 506 cases. Gynecol Oncol. 2015;138(1):89-93

Risk group criteria for tailoring adjuvant treatment in patients with endometrial cancer: a validation study of the Gynecologic Oncology Group criteria. J Gynecol Oncol 2015;26(1):32-39

Neoadjuvant and postoperative chemotherapy with paclitaxel plus cisplatin for the treatment of FIGO stage IB cervical cancer in pregnancy. Obstet Gynecol Sci 2014;57(6):539-543

Comparison of laparoscopic versus abdominal radical hysterectomy for FIGO stage IB and IIA cervical cancer with tumor diameter of 3 cm or greater. Int J Gynecol Cancer 2014;24(2):280-288

Efficacy of neoadjuvant chemotherapy in patients with FIGO stage IB1 to IIA cervical cancer: An international collaborative meta-analysis. Eur J Surg Oncol. 2013;39(2):115-124

Analysis of para-aortic lymphadenectomy up to the level of the renal vessels in apparent early-stage ovarian cancer. J Gynecol Oncol 2013. 24(1):29-36

Impact of complete cytoreduction leaving no gross residual disease associated with radical cytoreductive surgical procedures on survival in advanced ovarian cancer. Ann Surg Oncol. 2012;19:4059-67

Prognostic significance of systematic lymphadenectomy as part of primary debulking surgery in patients with advanced ovarian cancer. Gynecol Oncol. 2012;126:381-6

Comprehensive staging surgery including complete pelvic and para-aortic lymphadenectomy followed by adjuvant vaginal brachytherapy improves survival rates for intermediate-risk endometrial cancer patients. Gynecol Obstet Invest. 2012(74):68-75

Laparoscopic para-aortic lymphadenectomy in endometrial cancer patient with left-sided inferior vena cava. Gynecol Oncol. 2012;126(1):147-8

A model for prediction of parametrial involvement and feasibility of less radical resection of parametrium in patients with FIGO stage IB1 cervical cancer. Gynecol Oncol. 2012;126(1):82-6

Lymph-Vascular Space Invasion as a Significant Risk Factor for Isolated Para-aortic Lymph Node Metastasis in Endometrial Cancer: A Study of 203 Consecutive Patients. Ann Surg Oncol. 2011;18(1):58-64.

Para-aortic lymphadenectomy in the management of preoperative grade 1 endometrial cancer confined to the uterine corpus. Ann Surg Oncol. 2010.17(12):3234-40.

A validation study of new risk grouping criteria for postoperative treatment in stage IB cervical cancers without high-risk factors: Rethinking the Gynecologic Oncology Group criteria. Eur J Obstet Gynecol. 2009;147:91-6

Endometrial cancer invasion depends on cancer driven TNF-α and stromal-driven hepatocyte growth factor. Int J Cancer 2009;124:2528–38

Prognostic significance of the micropapillary pattern in patients with serous borderline ovarian tumors. Acta Obstet Gynecol Scand 2008;87: 476-8.

Pattern of Primary and Postop adjuvant concurrent chemoradiotherapy for uterine cervical cancer in Korea: Results of a multicenter retrospective study. J Women's Med. 2008;1(2):71-7.

Significance of postoperative CA-125 decline after cytoreductive surgery in stage IIIC/IV ovarian cancer. J Gynecol Oncol 2008:19(3);169-72

Clinical characteristics of struma ovarii. J Gynecol Oncol 2008:19(2);135-8

Does pretreatment HPV viral load correlate with prognosis in patients with early stage cervical carcinoma? J Gynecol Oncol 2008:19(2);113-6

Safety and immunogenicity of a vaccine targeting human papillomavirus types 6, 11, 16 and 18: a randomized, placebo-controlled trial in 176 Korean subjects. Int J Gynecol Cancer 2008;18:1013-9

Cervical cancer associated with pregnancy: results of a multicenter retrospective Korean study (KGOG-1006). Am J Obstet Gynecol. 2008;198(1):92.e1-6

Para-aortic lymphadenectomy improves survival in patients with intermediate to high-risk endometrial carcinoma. Acta Obstet Gynecol Scand 2008;87(12):1361-9.

Prognostic significance of the micropapillary pattern in patients with serous borderline ovarian tumors. Acta Obstet Gynecol Scand 2008;87(4):476-8.

Cervical cancer in Korea: Results of a multicenter retrospective Korean study (KGOG-1005) Int J Gynecol Cancer 2007;17:132-6.

Prognostic factors and expression of p53 and mdm-2 in uterine sarcomas Int J Gynecol Obstet. 2006;95(3):272-7.

Amniotic fluid embolism with isolated coagulopathy: a case report. J Reprod Med. 2006;51(1):64-6

Sonographic findings of placental lacunae and the prediction of adherent placenta in women with placenta previa totalis and prior Cesarean section. Ultrasound Obstet Gynecol. 2006;28(2):178-82.

Rare case of stage IA epithelial ovarian cancer with bone as the first site of recurrent metastasis. Int J Gynecol Cancer 2006;16 Suppl 1:322-6

Surgery for Ovarian Cancer 3rd Edition, Coauthor, Taylor and Francis Group through CRC Press. 2015

부인과학. 공저. 고려의학. 2015

부인과학. 공저. 고려의학. 2007

실용적 부인종양학. 공저. 군자출판사. 2007

Cell and Molecular Biology of Endometrial Carcinoma, Coauthor, Springer, 2003

최신 갱년기관리. 공저. 아주대학교의료원 갱년기연구회. 연구사. 1999

21세기 암정복교실. 공저. 아주대학교 의과대학. 정음문화사. 1996

부인과종양학. 공저. 대한부인종양*콜포스코피학회. 칼빈서적. 1995